GlassScriptPhysician profile
Rachel E Heneghan
NPI 1730448176
$5,572.01
in general payments reported to CMS, 2019-2025
9 companies · $1,826 in 2025
The $1,826 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $780 · 2021: $994 · 2022: $254 · 2023: $1,653 · 2024: $63.83 · 2025: $1,826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,007 · Food and Beverage: $1,536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,007.45 |
| Food and Beverage | $1,535.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $3,069.85 | 2023-2025 | Amds-Ascyrus Medical, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive |
| Edwards Lifesciences Corporation | $1,884.72 | 2020-2025 | Edwards Sapien Xt Transcatheter Heart Valve (Thv), Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $380.75 | 2021-2023 | Epic |
| Medtronic, INC. | $129.31 | 2022 | |
| Medical Device Business Services, INC. | $43.00 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.02 | 2022-2024 | Lifevest |
| Kls-Martin L.P. | $16.32 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $14.89 | 2022 | |
| Altathera Pharmaceuticals LLC | $11.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Heneghan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.